Evaluating the efficacy of 10-color muli-parameter FCM-based MRD methods in acute myeloid leukemia

Evaluating the efficacy of 10-color muli-parameter FCM-based MRD methods in acute myeloid leukemia - EV10CMRD study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000058313

Enrollment

150

Registered

2025-07-07

Start date

2017-07-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myeloid leukemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: AML patients whose samples were preserved based on KCNET protocol in Kyushu University Hospital

Exclusion criteria

Exclusion criteria: Key exclusion criteria are defined by the preceding KCNET protocol

Design outcomes

Primary

Measure	Time frame
Comparison of WT1-mRNA levels vs. 10-color MFC-MRD levels at the time of pre-relapse phases including 3 and 6 months before clinical release of AML(retrospective comparison)	—

Countries

Japan

Contacts

Public ContactYoshikane Kikushige

Kyushu University Hospital Center for Cellular and Molecular medicine

kikusige@intmed1.med.kyushu-u.ac.jp092-642-5947

Outcome results